Legal Representation
Attorney
Michelle P. Ciotola
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 4, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 24, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 4, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 19, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 19, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 29, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 14, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 10, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Apr 10, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 10, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 3, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Apr 3, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 3, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 26, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 26, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 24, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Feb 24, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 24, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 24, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 24, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 24, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 28, 2019 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Aug 28, 2019 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Aug 28, 2019 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Feb 28, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 28, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 28, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 17, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 17, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 17, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 14, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 12, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 12, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 12, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 11, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 2, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 29, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for immuno-oncology and autoimmune disease; pharmaceutical preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; veterinary preparations for immuno-oncology and autoimmune disease; veterinary preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; biotechnological preparations for medical and veterinary use, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases
Class 042
Research and consultancy in the field of biotechnology; research and development in the field of biotechnology; scientific and technical consultation, namely, engineering evaluations and appraisals in the fields of science and technology; scientific and technology research in the field of immuno-oncology and autoimmune disease; laboratory research and analysis services in the field of immuno-oncology and autoimmune disease; scientific chemistry, biology and biotechnology laboratories; scientific laboratory services; laboratory testing, research and development of new products for others; conducting clinical trials for others in the field of medicines, molecules and medical devices; medical laboratory analysis services relating to the treatment of persons; medical laboratory services, including sample analysis; medical laboratory analysis services
Class 044
Medical services; pharmaceutical advice
Classification
International Classes
005
042
044